We just received data on a new analyst forecast for $CVX. Piper Sandler gave a rating of 'Overweight' for $CVX.
$CVX Analyst Ratings
Wall Street analysts have issued reports on $CVX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 08/18/2025
- Evercore ISI Group issued a "Outperform" rating on 07/31/2025
- Wells Fargo issued a "Overweight" rating on 07/23/2025
- Mizuho issued a "Outperform" rating on 05/13/2025
- Redburn Atlantic issued a "Sell" rating on 04/23/2025
- UBS issued a "Buy" rating on 04/07/2025
To track analyst ratings and price targets for $CVX, check out Quiver Quantitative's $CVX forecast page.
$CVX Price Targets
Multiple analysts have issued price targets for $CVX recently. We have seen 9 analysts offer price targets for $CVX in the last 6 months, with a median target of $168.0.
Here are some recent targets:
- Ryan Todd from Piper Sandler set a target price of $168.0 on 08/18/2025
- Josh Silverstein from UBS set a target price of $186.0 on 08/04/2025
- Stephen Richardson from Evercore ISI Group set a target price of $180.0 on 07/31/2025
- Roger Read from Wells Fargo set a target price of $178.0 on 07/23/2025
- Paul Cheng from Scotiabank set a target price of $160.0 on 07/11/2025
- Betty Jiang from Barclays set a target price of $156.0 on 07/07/2025
- Nitin Kumar from Mizuho set a target price of $186.0 on 05/13/2025
$CVX Congressional Stock Trading
Members of Congress have traded $CVX stock 15 times in the past 6 months. Of those trades, 7 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CVX stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/25 and 1 sale worth up to $15,000 on 04/07.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/14, 05/05 and 0 sales.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $100,000 on 05/13 and 1 sale worth up to $50,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 04/07 and 2 sales worth up to $100,000 on 05/12, 05/08.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CVX Hedge Fund Activity
We have seen 1,722 institutional investors add shares of $CVX stock to their portfolio, and 1,915 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 83,702,101 shares (+652139.5%) to their portfolio in Q2 2025, for an estimated $11,985,303,842
- ROYAL BANK OF CANADA added 11,098,363 shares (+106.8%) to their portfolio in Q2 2025, for an estimated $1,589,174,597
- GQG PARTNERS LLC removed 8,693,136 shares (-99.1%) from their portfolio in Q2 2025, for an estimated $1,244,770,143
- GAMMA INVESTING LLC removed 5,380,883 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $770,488,636
- SWISS NATIONAL BANK removed 4,915,035 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $822,236,205
- STATE STREET CORP removed 4,559,031 shares (-3.2%) from their portfolio in Q2 2025, for an estimated $652,807,648
- BLACKROCK, INC. removed 3,793,249 shares (-3.1%) from their portfolio in Q2 2025, for an estimated $543,155,324
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
